274 related articles for article (PubMed ID: 9607375)
1. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy.
Roman MJ; Alderman MH; Pickering TG; Pini R; Keating JO; Sealey JE; Devereux RB
Am J Hypertens; 1998 Apr; 11(4 Pt 1):387-96. PubMed ID: 9607375
[TBL] [Abstract][Full Text] [Related]
2. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
White WB; Cleveland JM; Rolleri RL;
J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
[TBL] [Abstract][Full Text] [Related]
3. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
4. Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Azizi M; Perdrix L; Bobrie G; Frank M; Chatellier G; Ménard J; Plouin PF
J Hypertens; 2014 Oct; 32(10):2038-44; discussion 2044. PubMed ID: 24983187
[TBL] [Abstract][Full Text] [Related]
5. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
Grandi AM; Solbiati F; Laurita E; Maresca AM; Nicolini E; Marchesi C; Gianni M; Guasti L; Venco A
Am J Hypertens; 2008 Feb; 21(2):231-7. PubMed ID: 18174880
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
7. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients.
Girerd X; Giannattasio C; Moulin C; Safar M; Mancia G; Laurent S
J Am Coll Cardiol; 1998 Apr; 31(5):1064-73. PubMed ID: 9562008
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group.
Weir MR; Reisin E; Falkner B; Hutchinson HG; Sha L; Tuck ML
Am J Hypertens; 1998 Aug; 11(8 Pt 1):914-20. PubMed ID: 9715782
[TBL] [Abstract][Full Text] [Related]
9. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
[TBL] [Abstract][Full Text] [Related]
10. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
Verdecchia P; Schillaci G; Reboldi GP; Sacchi N; Bruni B; Benemio G; Porcellati C
Blood Press Monit; 2000 Jun; 5(3):187-93. PubMed ID: 10915233
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
[TBL] [Abstract][Full Text] [Related]
13. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M
Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
[TBL] [Abstract][Full Text] [Related]
14. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
[TBL] [Abstract][Full Text] [Related]
15. Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients.
Petrovic I; Petrovic D; Vukovic N; Zivanovic B; Dragicevic J; Vasiljevic Z; Babic R
J Int Med Res; 2005; 33 Suppl 1():39A-49A. PubMed ID: 16222899
[TBL] [Abstract][Full Text] [Related]
16. Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis.
Roush GC; Abdelfattah R; Song S; Kostis JB; Ernst ME; Sica DA
J Hypertens; 2018 Jun; 36(6):1247-1255. PubMed ID: 29465713
[TBL] [Abstract][Full Text] [Related]
17. The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
Fox JC; Leight K; Sutradhar SC; Demopoulos LA; Gleim GW; Lewin AJ; Bakris GL
J Clin Hypertens (Greenwich); 2004 Aug; 6(8):437-42; quiz 443-4. PubMed ID: 15308882
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study on behalf of the RACE study group.
Agabiti-Rosei E; Ambrosioni E; Dal Palù C; Muiesan ML; Zanchetti A
J Hypertens; 1995 Nov; 13(11):1325-34. PubMed ID: 8984131
[TBL] [Abstract][Full Text] [Related]
19. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
20. [A decrease in left ventricular hypertrophy and the dynamics of the parameters of circadian BP monitoring under the influence of ramipril in patients with essential arterial hypertension].
Pekarskiĭ SE; Vorozhtsova IN; Mordovin VF
Ter Arkh; 1997; 69(4):18-20. PubMed ID: 9213948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
